Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
加入 April 2009
104 正在關注 10.5M 粉絲
UniQure said that the benefits of its Huntington’s disease gene therapy drug AMT-130 were not as good after four years as they were after three years in a small trial
